Australia, Jan. 13 -- Asymptote Genetic Medicines Inc., owns the trademark (2569634) for 'ASYMPTOTE GENETIC MEDICINES' till May 28, 2035.
Status: protected:
Registered/protected
Class: 42 [Biological research; biological research and analysis; development of gene-based medicines; gene therapy research; laboratory research services in the field of gene expression; medical research; medical research services; research in the field of gene editing technology; research in the field of synthetic biology; software as a service (SaaS) services featuring software using artificial intelligence (AI) for engaging in biological, medical, and gene therapy research; software as a service (SaaS) services, namely, hosting software for use by others for engaging in biological, medical, and gene therapy research; providing laboratory research services in the field of gene expression, namely, cancer biology; testing, inspection, research, or development of pharmaceutical preparations for gene therapy.]
Type of Mark: Word
Date of Acceptance: Nov. 5, 2025
Registration Advertised: Jan. 12
For further details contact Franke Hyland Pty. Ltd. and Jonathan Pearce SoCal IP Law Group LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2569634.
Disclaimer: Curated by HT Syndication.
